Haleon plc (HLNCF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:22PM EDT
| Previous Close | 4.0200 |
| Open | 4.1189 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 4.0946 - 4.1189 |
| 52 Week Range | 3.4000 - 4.5000 |
| Volume | |
| Avg. Volume | 41,725 |
| Market Cap | 37.532B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 29.25 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.08 (1.84%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | N/A |
- Simply Wall St.
Haleon plc (LON:HLN) Shares Could Be 24% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
- Zacks
Pharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
- Zacks
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
© 2024 Yahoo. All rights reserved.